Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

CTX-M-15-Type Extended-Spectrum Beta-Lactamase-Producing Escherichia coli as Causative Agent of Bovine Mastitis.

In the present study, 3 quarter milk samples from 3 cows showing clinical signs of mastitis were investigated. Three Escherichia coli were isolated and were found resistant to ceftiofur and cefquinome. The isolates were detected as extended-spectrum beta-lactamase (ESBL) producers by the Clinical and Laboratory Standards Institute (CLSI) ESBL screening test and combined disc method. CTX-M- and TEM-type beta-lactamase genes (blaCTX-M blaTEM) were detected by polymerase chain reaction in the isolates. Sequencing of blaCTX-M and blaTEM genes showed that the isolates were both TEM-1- and CTX-M-15-type beta-lactamase producers. The isolates were tested by agar disc diffusion test for susceptibility to various classes of antibiotics (aminoglycosides, quinolones, phenicols, folate pathway inhibitors, and tetracyclines), and they were determined as multidrug resistant. Therefore, this is the first report indicating the involvement of multidrug-resistant CTX-M-15-type ESBL-producing E. coli as a cause of bovine mastitis in Turkey.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app